NRXS Neuraxis, Inc.
$7.36▲ +1.52%
Healthcare
Other
Volume 38.9K
Avg Volume (10D) 221.2K
Key Metrics & Fundamentals
Market Cap
$92.43M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.21 - 9.33
% vs 50 MA
8.75%
% vs 200 MA
11.02%
RSI-14
53.0
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.38
Free Cash Flow
-$1.04M
Gross Rev
$1.93M
Gross Profit
$1.66M
EBITDA
-$2.05M
COGS
$272,573
Operating Exp
$3.78M
Operating Income
-$2.12M
EBIT
-$2.12M
Pretax Income
-$2.09M
Net Income
-$2.09M
EPS (Diluted)
-0.19
Price & Volume History
Loading chart…
Recent News
NeurAxis to Host Third Quarter 2026 Results and Business Update Call on Monday, November 9, 2026
GlobeNewswire · Oct 27, 2026 7:00 AM ET
NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives
GlobeNewswire · Oct 15, 2026 9:18 AM ET
NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer
GlobeNewswire · Sep 29, 2026 7:00 AM ET
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
GlobeNewswire · Sep 16, 2026 9:00 AM ET
NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference
GlobeNewswire · Sep 16, 2026 7:00 AM ET
Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?
Zacks · Sep 15, 2026 11:11 AM ET
iAccess Alpha Virtual Best Ideas Fall Investment Conference Begins Today with Updated Presentation Schedule
ACCESS Newswire · Sep 15, 2026 8:00 AM ET
Is Kodak having a "Kodak moment?" 2 watchlist stocks.
Zacks · Sep 12, 2026 1:51 AM ET
iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026
ACCESS Newswire · Sep 8, 2026 9:00 AM ET
NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up
Zacks · Aug 14, 2026 11:42 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NRXS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.